Clinical results of cytoreduction and HIPEC for malignant peritoneal mesothelioma

Peritoneal Carcinomatosis: A Multidisciplinary Approach

Volumn , Issue , 2007, Pages 343-355

  Alexander, H Richard ^a   Hanna, Nader ^a   Pingpank, James F ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; HYPERTHERMIC THERAPY; INFUSION; MESOTHELIOMA; METHODOLOGY; MINIMALLY INVASIVE SURGERY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PERITONEUM TUMOR; REGIONAL PERFUSION; REVIEW; TREATMENT OUTCOME;

CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; MESOTHELIOMA; PERITONEAL NEOPLASMS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME;

EID: 34548456059     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-48993-3_22     Document Type: Chapter

References (28)

1. Hassan R, Alexander R (2005) Nonpleural mesotheliomas: mesothelioma of the peritoneum, tunica vaginalis, and pericardium. Hematol Oncol Clin North Am 19(6):1067-1087
2. Suzuki Y (1992) Diagnostic criteria for human diffuse malignant mesothelioma. Acta Pathol Jpn 42(11):767-786
3. Kannerstein M, Churg J (1977) Peritoneal mesothelioma. Hum Pathol 8:83-94
4. Nonaka D, Kusamura S, Baratti D, Casali P, Cabras AD, Younan R, Rosai J, Deraco M (2005) Diffuse malignant mesothelioma of the peritoneum: a clinicopathological study of 35 patients treated locoregionally at a single institution. Cancer 104(10):2181-2188
5. Deraco M, Nonaka D, Baratti D, Casali P, Rosai J, Younan R, Salvatore A, Cabras Ad AD, Kusamura S (2006) Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol 13(2):229-237
6. Averbach AM, Sugarbaker PH (1996) Peritoneal mesothelioma: treatment approach based on natural history. Cancer Treat Res 81:193-211:193-211
7. Sugarbaker PH, Welch LS, Mohamed F, Glehen O (2003) A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin N Am 12(3):605-621
8. Kebapci M, Vardareli E, Adapinar B, Acikalin M (2003) CT findings and serum ca 125 levels in malignant peritoneal mesothelioma: report of 11 new cases and review of the literature. Eur Radiol 13(12):2620-2626
9. Antman KH (1981) Clinical presentation and natural history of benign and malignant mesothelioma. Semin Oncol 8(3):313-320
10. van Gelder T, Hoogsteden HC, Versnel MA, de Beer P, Vandenbroucke JP, Planteydt HT (1989) Malignant peritoneal mesothelioma: A series of 19 cases. Digestion 43:222-227
11. Antman KH, Blum RH, Greenberger JS, Flowerdew G, Skarin AT, Canellos GP (1980) Multimodality therapy for malignant mesothelioma based on a study of natural history. Am J Med 68:356-362
12. Hassan R, Alexander R, Antman K, Boffetta P, Churg A, Coit D, et al (2006) Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference. Ann Oncol, in press
13. Markman M, Kelsen D (1992) Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma. J Cancer Res Clin Oncol 118(7):547-550
14. Langer CJ, Rosenblum N, Hogan M, Nash S, Bagchi P, LaCreta FP, Catalano R, Comis RL, O'Dwyer PJ (1993) Intraperitoneal cisplatin and etoposide in peritoneal mesothelioma: favorable outcome with a multimodality approach. Cancer Chemother Pharmacol 32:204-208
15. Antman K, Osteen R, Klegar K, Amato DA, Pomfret EA, Larson DA, Corson JM (1985) Early peritoneal mesothelioma: a treatable malignancy. Lancet 2(8462):977-981
16. Alexander H.R., Kavanagh MA, Libutti SK, Pingpank J.F (2004) Regional Therapy of Cancer Using Continuous Hyperthermic Peritoneal Perfusion or Vascular Isolation and Perfusion Techniques. In: Figg W, McLeod HL, editors. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Totowa: Humana Press Inc., p327-348
17. Yan TD, Haveric N, Carmignani CP, Chang D, Sugarbaker PH (2005) Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer 103(4): 839-849
18. Hassan R, Remaley AT, Sampson ML, Zhang J, Cox DD, Pingpank J, Alexander R, Willingham M, Pastan I, Onda M (2006) Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer. Clin Cancer Res 12(2):447-453
19. Brigand C, Monneuse O, Mohamed F, Sayag-Beaujard AC, Isaac S, Gilly FN, Glehen O (2006) Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study. Ann Surg Oncol 13(3):405-412
20. Deraco M, Casali P, Inglese MG, Baratti D, Pennacchioli E, Bertulli R, Kusamura S (2003) Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion. J Surg Oncol 83(3):147-153
21. Eltabbakh GH, Piver MS, Hempling RE, Recio FO, Intengen ME (1999) Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma. J Surg Oncol 70(1):6-12
22. Mongero LB, Beck JR, Kroslowitz RM, Argenziano M, Chabot JA (1999) Treatment of primary peritoneal mesothelioma by hyperthemic intraperitoneal chemotherapy. Perfusion 14(2):141-145
23. Loggie BW, Fleming RA, McQuellon RP, Russell GB, Geisinger KR, Levine EA (2001) Prospective trial for the treatment of malignant peritoneal mesothelioma. Am Surg 67(10):999-1003
24. Park BJ, Alexander HR, Libutti SK, Wu P, Royalty D, Kranda KC, Bartlett DL (1999) Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP). Ann Surg Oncol 6(6):582-590
25. Sebbag G, Yan H, Shmookler BM, Chang D, Sugarbaker PH (2000) Results of treatment of 33 patients with peritoneal mesothelioma. Br J Surg 87(11):1587-1593
26. Sugarbaker PH, Yan TD, Stuart OA, Yoo D (2006) Comprehensive management of diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol 32(6):686-691
27. McQuellon RP, Loggie BW, Lehman AB, Russell GB, Fleming RA, Shen P, Levine EA (2003) Long-term survivorship and quality of life after cytoreduc tive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 10(2):155-162
28. Alexander H.R., Mavroukakis SM, Libutti SK, Pingpank J.F., Beresnev T, Marden S, Steinberg SM, Liewehr DJ (2004) Impact of tumor resection (Rxn) and intraperitoneal (IP) chemotherapy (CHRx) on health related quality of life (HRQL) in patients (Pts) with peritoneal surface malignancies (PSM). Society of Surgical Oncology 57th Annual Cancer Symposium. Ann Surg Oncol S109